Navigation Links
Imprimis Pharmaceuticals, Inc. Announces Its Attendance at the American Academy of Ophthalmology in New Orleans, Nov. 16-19
Date:11/8/2013

(ARM™), in order to assess potential for commercialization. Following this evaluation process, including clinical development, the company may choose to pursue FDA approval through the FDA's Section 505(b)(2) development pathway, or selectively make its treatment options available to the market through pharmacy compounding.  In addition, Imprimis expects to seek partnerships with wholesalers in order to make its drug delivery technologies available to compounding pharmacies across North America.  The company's current focus is in the Ophthalmology, Wound Management, Urology and Pain therapeutic areas.

SAFE HARBOR

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause Imprimis' results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include Imprimis' ability to enter into licensing arrangements with pharmacies, physicians and healthcare organizations or to otherwise commercialize its formulations, its ability to obtain intellectual property protection for its assets, the success of additional research and development activities related to its formulations, its ability to accurately estimate its expenses and cash burn, its ability to raise additional funds, its ability to acquire, develop, commercialize or market new formulations and to enter into strategic alliances and transactions,  the projected size of the potential market for our product candidates, unexpected new data, safety and technical issues, regulatory and market developments impacting compo
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
2. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
3. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
4. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
5. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
6. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
7. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
8. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
9. Imprimis Announces Key Leadership Appointments
10. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
11. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... NEWARK, N.J. , Aug. 27, 2015  Symbiomix ... Phase 3 clinical study, the second pivotal trial of ... the treatment of bacterial vaginosis (BV). Earlier this year ... for SYM-1219. Symbiomix expects to finish this second pivotal ... a New Drug Application (NDA) filing with the U.S. ...
(Date:8/27/2015)... -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN ) today announced that ... a corporate overview and business update at two investor conferences ... . , 22 nd Annual NewsMakers in ... Millennium Broadway Hotel. , Rodman & Renshaw Annual Global ... Regis Hotel. To access the live audio webcast ...
(Date:8/26/2015)... PUNE, India , August 27, 2015 ... market research reports reviewing the genotyping technology, ... as well as single nucleotide polymorphism (SNP) ... ReportsnReports.com. Complete report on genotyping ... spread across 200 pages, profiling 10 major ...
Breaking Medicine Technology:Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4SciClone To Present At Two Investor Conferences On September 10, 2015 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5
... The law firm of Childers, Schlueter & Smith, LLC of ... will be held during the week of July 26, 2010 .  The ... States District Court, Northern District of Georgia , Atlanta Division. , ... The lawsuit alleges that the drug makers and ...
... Inc. (NYSE Amex: MHH ) ("Mastech"), a national provider of Information Technology ... discuss the results of its second quarter ended June 30, 2010 . ... 9:00 a.m. Eastern Time and will be hosted by Mr. ... , , ...
Cached Medicine Technology:Childers, Schlueter & Smith, LLC Set for Reglan/metoclopramide Jury Trial Involving Woman's Development of Tardive Dyskinesia 2Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010 2
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor ... a third doctoral program at its main campus in Reading: Doctor of Nursing Practice. ... designed to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... ... ... Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a free-standing emergency ... at US Highway 19 North and Highlands Boulevard, less than eight miles from the main ... is slated to begin in September 2015. , The new 24-bed facility will ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... NetDimensions ... , “The companies selected have the platforms required not only to effectively deliver, curate ... Taylor, President of Training Industry, Inc. , For six consecutive years, NetDimensions has ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... they have launched their new corporate website http://www.Z-Medica.com , to further support ... website that was launched last year. , “We launched a branded website ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Z-Medica® Launches New Corporate Website 2
... Heavy alcohol consumption, specifically three or more glasses of ... of death from pancreatic cancer, according to a report ... Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral cavity, ...
... , , , , ... AUDIO: Washington University,s Victoria Fraser, MD, talks about ... , , , , ... , , , , , , ...
... March 14 (HealthDay News) -- A lack of vitamin ... but levels of the vitamin don,t decrease as the ... insufficiency has been associated with a variety of clinical ... strength, mood and cognitive dysfunction, autoimmune disorders such as ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay News) -- Women ... fatty acids found in that meal choice -- have a ... suggests. This latest evidence of a protective link between ... found the same benefit. In this study, Harvard researchers performed ...
... March 14, 2011 -- Some physicians are prescribing opioids such ... a new study led by St. Michael,s Hospital and the ... opioid-related deaths occur among patients treated by physicians who frequently ... may not be doing so safely. "We found that ...
... technique called microdissection testicular sperm extraction (TESE) can effectively ... of adult male childhood cancer survivors who were previously ... result, many of the men were subsequently able to ... The findings offer a new option for many cancer ...
Cached Medicine News:Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Novel strategies target health care-associated infections 2Health News:Novel strategies target health care-associated infections 3Health News:Novel strategies target health care-associated infections 4Health News:Study: Lack of Vitamin D May Precede Onset of Parkinson's 2Health News:Eating Fish Might Protect Your Eyesight 2Health News:Eating Fish Might Protect Your Eyesight 3Health News:Painkiller prescribing varies dramatically among family physicians: study 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 3
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
Inquire...
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
... A revolutionary urological imaging system ... that translate into improved patient ... 1k imaging technology physicians and ... see more anatomical detail and ...
Medicine Products: